{{ variable.name }} : {{ variable.values[selectedVariantsIndex[variable_index]].name }}
Quantity:
Retatrutide is an investigational compound designed to interact with three metabolic hormone receptors: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon.
Its multi-receptor activity has made it a subject of scientific investigation into metabolic regulation, glucose homeostasis, energy balance, and body weight regulation. Research explores how these signaling pathways interact and their potential implications for metabolic science, including areas relevant to obesity and type 2 diabetes research.
Retatrutide remains under clinical investigation, and its pharmacological properties and potential applications continue to be evaluated in scientific studies.